Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis.
Blasi M, Eichhorn ME, Christopoulos P, Winter H, Heußel CP, Herth FJ, El Shafie R, Kriegsmann K, Kriegsmann M, Stenzinger A, Bischoff H, Thomas M, Kuon J. Blasi M, et al. Among authors: stenzinger a. BMC Pulm Med. 2022 Jun 28;22(1):255. doi: 10.1186/s12890-022-02043-6. BMC Pulm Med. 2022. PMID: 35761214 Free PMC article.
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W. Warth A, et al. Among authors: stenzinger a. J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393100
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma.
Lederlin M, Puderbach M, Muley T, Schnabel PA, Stenzinger A, Kauczor HU, Heussel CP, Herth FJ, Hoffmann H, Dienemann H, Weichert W, Warth A. Lederlin M, et al. Among authors: stenzinger a. Eur Respir J. 2013 Apr;41(4):943-51. doi: 10.1183/09031936.00056612. Epub 2012 Jul 26. Eur Respir J. 2013. PMID: 22835610 Free article.
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.
Warth A, Penzel R, Lindenmaier H, Brandt R, Stenzinger A, Herpel E, Goeppert B, Thomas M, Herth FJ, Dienemann H, Schnabel PA, Schirmacher P, Hoffmann H, Muley T, Weichert W. Warth A, et al. Among authors: stenzinger a. Eur Respir J. 2014 Mar;43(3):872-83. doi: 10.1183/09031936.00018013. Epub 2013 Aug 29. Eur Respir J. 2014. PMID: 23988776 Free article.
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.
Warth A, Cortis J, Soltermann A, Meister M, Budczies J, Stenzinger A, Goeppert B, Thomas M, Herth FJ, Schirmacher P, Schnabel PA, Hoffmann H, Dienemann H, Muley T, Weichert W. Warth A, et al. Among authors: stenzinger a. Br J Cancer. 2014 Sep 9;111(6):1222-9. doi: 10.1038/bjc.2014.402. Epub 2014 Jul 22. Br J Cancer. 2014. PMID: 25051406 Free PMC article.
Genetic changes of non-small cell lung cancer under neoadjuvant therapy.
Warth A, Endris V, Stenzinger A, Penzel R, Harms A, Duell T, Abdollahi A, Lindner M, Schirmacher P, Muley T, Dienemann H, Fink L, Morresi-Hauf A, Pfarr N, Weichert W. Warth A, et al. Among authors: stenzinger a. Oncotarget. 2016 May 17;7(20):29761-9. doi: 10.18632/oncotarget.8858. Oncotarget. 2016. PMID: 27105513 Free PMC article.
462 results